tiprankstipranks
Scinai Immunotherapeutics regains compliance with Nasdaq
PremiumThe FlyScinai Immunotherapeutics regains compliance with Nasdaq
3M ago
Scinai Immunotherapeutics Restructures Debt, Boosts Equity
Premium
Company Announcements
Scinai Immunotherapeutics Restructures Debt, Boosts Equity
3M ago
Scinai Secures $2M Investment Boost
Premium
Company Announcements
Scinai Secures $2M Investment Boost
3M ago
Scinai Immunotherapeutics Amends Shareholder Terms
PremiumCompany AnnouncementsScinai Immunotherapeutics Amends Shareholder Terms
4M ago
Scinai Immunotherapeutics’ IL-17 nanoAb receives positive regulatory feedback
Premium
The Fly
Scinai Immunotherapeutics’ IL-17 nanoAb receives positive regulatory feedback
4M ago
Scinai’s Psoriasis Treatment Shows Promising Results
Premium
Company Announcements
Scinai’s Psoriasis Treatment Shows Promising Results
4M ago
Scinai Immunotherapeutics Strives for Nasdaq Compliance
PremiumCompany AnnouncementsScinai Immunotherapeutics Strives for Nasdaq Compliance
5M ago
Scinai Immunotherapeutics receives updated LOI from EIB
Premium
The Fly
Scinai Immunotherapeutics receives updated LOI from EIB
5M ago
Scinai Immunotherapeutics reports Q1 EPS ($0.001c) vs ($0.003) last year
Premium
The Fly
Scinai Immunotherapeutics reports Q1 EPS ($0.001c) vs ($0.003) last year
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100